medigraphic.com
ISSN 2221-2434 (Electronic)

2020, Number 3

<< Back Next >>

Finlay 2020; 10 (3)

Characterization of positive and suspected COVID-19 cases with comorbidities

Peña GY, Suárez PA, Arruebarrena BNM

Language: Spanish
References: 15
Page: 314-319
PDF size: 258.20 Kb.


ABSTRACT

Background: factors associated with the severity and worse prognosis in SARS-CoV-2 infection have been described, such as age, the presence of chronic diseases such as diabetes, arterial hypertension and those that compromise the immune system.
Objective: to characterize positive and suspected COVID-19 cases with comorbidities in the Puerto Padre municipality between March and May 2020.
Methods: a descriptive cross-sectional study was carried out using the information obtained from epidemiological surveys and medical records in the Puerto Padre municipality. The study population was made up of 176 patients. The variables were evaluated: age, sex, symptoms, signs, and comorbidities. For this study, data from epidemiological surveys of the cases detected in epidemiological surveillance and medical records were used. Data were processed using descriptive statistics: calculation of percentages, mean and standard deviation and their confidence interval for 95 % reliability.
Results: the mean age was 50 years in suspects and 37 years in confirmed, male sex (53.80 %) prevailed in suspects and female (60.00 %) in positives. The most frequent signs and symptoms in confirmed cases were: fever (28.57 %), cough, nasal congestion and rhinorrhea (14.29 %). In both groups, the most frequent comorbidities were arterial hypertension 119 (69.59 %), smoking 93 (54.39 %), bronchial asthma 46 (26.90 %) and diabetes mellitus 29 (16.96 %).
Conclusions: positive and suspected COVID-19 cases with comorbidities were characterized, the most frequent being hypertension, smoking, bronchial asthma, diabetes mellitus, and obesity.


REFERENCES

  1. Serra MA. Las enfermedades crónicas no transmisibles y la pandemia por COVID-19. Finlay[Internet]. 2020[citado 12 Jul 2020];10(2):[aprox. 15p.]. Disponible en: http://www.revfinlay.sld.cu/index.php/finlay/article/view/846.

  2. Cai Q, Fengjuan Ch, Luo F, Liu X, Wang T, Wu Q, et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care. 2020;43(7):200576.

  3. Ministerio de Salud Pública. Parte del cierre del 19 de mayo a las 12 de la noche[Internet]. La Habana:MINSAP;2020[citado 25 May 2020]. Disponible en: https://salud.msp.gob.cu/?p=5341.

  4. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Inter J Infect Dis. 2020;94(20):2132-9.

  5. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62.

  6. Danser AJ, Epstein M, Batlle D. Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon Renin-Angiotensin system blockers. Hypertension. 2020;75(6):1382-5.

  7. Madjid M, Safavi P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: A review. JAMA Cardiol. 2020;5(7):831-40.

  8. Guanche H. COVID-19. Un reto para los profesionales de la salud. Rev haban cienc méd[Internet]. 2020[citado 15 May 2020];19(2):e3284. Disponible en: Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3284/2484 .

  9. Suárez V, Suárez M, Oros S, Ronquillo E. Epidemiología de COVID-19 en México: del 27 de febrero al 30 de abril de 2020. Rev Clín Esp[Internet]. 2020[citado 17 Jun 2020];2(7):[aprox. 10p.]. Disponible en: https://www.clinicalkey.es/#!/content/journal/1-s2.0-S0014256520301442.

  10. Riverón LJ, Vergara M, Lluch AP, Alba Y, Ortíz AY. Pacientes sospechosos de COVID-19 con RT-PCR negativo atendidos en un centro de aislamiento en Las Tunas. Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta[Internet]. 2020[citado 23 Ago 2020];45(4):[aprox. 12p.]. Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/2304.

  11. Cobas L, Mezquia N, Armenteros SS. Características clínicas de pacientes con sospecha de COVID-19 ingresados en el hospital "Frank País García", La Habana. Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta[Internet]. 2020[citado 23 Ago 2020]; 45(4):[aprox. 8p.]. Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/2339.

  12. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(1):1708-20.

  13. Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775-6.

  14. Goire G. Repercusión en la salud cardiovascular del COVID-19. Rev Cuban Cardiol Cir Cardiovas[Internet]. 2020[citado 14 Jun 2020];26(2):[aprox. 10p.]. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/972.

  15. Carretero J, Arévalo JC, Carrasco FJ. Obesidad y coronavirus 2019: una relación de riesgo. Rev Clín Esp[Internet]. 2020[citado 17 Jun 2020];22(6):[aprox. 8p.]. Disponible en: https://www.clinicalkey.es/#!/content/journal/1-s2.0-S0014256520301168.




2020     |     www.medigraphic.com